Hinge Health, Inc. (HNGE) Stock Chart - Revenue & Earnings | Quarter Chart

Select dashboard New custom dashboard
Income Statement

Revenue by Product

Reportable Segment
025M50M75M100M125M150M175M200MQ1 2026025M50M75M100M125M150M175M200MQ1 2026

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
062M125M188M250M312M375M438M500MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Operating Expenses

Research And Development ExpensesSelling And Marketing ExpensesGeneral And Administrative ExpensesOther Expenses
0100M200M300M400M500M600M700M800MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

EBITDA

EBITDA
-700M-608M-515M-422M-330M-238M-145M-52M40MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

EPS

EPSEPS Diluted
001222344Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Revenue Variation (%)

Revenue Variation
02581012151820Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
050100150200250300350400Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Revenue YoY Variation (%)

Revenue YoY Variation
0815223038455260Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
01K2K3K4K6K7K8K9KQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Price-to-Earning Ratio

P/E Ratio
-600-520-440-360-280-200-120-4040Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Income Breakdown

Rule Of 40 (EBITDA)Rule Of 40 (FCF)
0255075100125150175200Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Per Share Metrics

Operating IncomeTotal Other Income Expenses NetNet Income
038M75M112M150M188M225M262M300MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
001222344Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Cash Flow Statement

Operating Cash Flow

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
012344567Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Free Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
025M50M75M100M125M150M175M200MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Cash Flow to Debt Ratio

Cash At End Of Period
050M100M150M200M250M300M350M400MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Balance Sheet

Current Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
011M22M34M45M56M68M79M90MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Quick Ratio

Total AssetsTotal Liabilities
0250M500M750M1B1B2B2B2BQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Cash & Equivalents

Total Current AssetsTotal Non Current Assets
0112M225M338M450M562M675M788M900MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Total Assets

Total Current LiabilitiesTotal Non Current Liabilities
062M125M188M250M312M375M438M500MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Total Liabilities

Total Stockholders Equity
062M125M188M250M312M375M438M500MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Shareholders Equity

Debt To Equity
000001111Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Asset Composition

Cash And Cash EquivalentsShort Term Investments
075M150M225M300M375M450M525M600MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Debt Structure

Short Term DebtLong Term Debt
02M5M8M10M12M15M18M20MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Key Metrics

Hinge Health, Inc. (HNGE) quarterly earnings & revenue

Hinge Health, Inc. (HNGE) reported revenue of $182.31M for Q1 2026, up 47.2% year-over-year, with net income of $35.13M and diluted EPS of $0.41.

Over the last four reported quarters, Hinge Health, Inc. generated $646.34M in revenue and $-614.45M in net income.

Hinge Health, Inc.'s next earnings report is scheduled for August 4, 2026 after market close; analysts estimate EPS of $0.59.

Hinge Health, Inc. quarterly results

Fiscal quarterRevenueRevenue YoYNet incomeEPS (diluted)
Q1 2026$182.31M+47.2%$35.13M$0.41
Q4 2025$170.73M+45.6%$32.09M$0.37
Q3 2025$154.21M+53.3%$-1.84M$-0.02
Q2 2025$139.10M+54.9%$-679.83M$-7.38
Q1 2025$123.83M+49.7%$121.31M$1.55
Q4 2024$117.26M+43.8%$27.12M$0.35
Q3 2024$100.61M+23.7%$341,000$0.00
Q2 2024$89.83M+28.6%$-12.93M$-0.14

📈 Analysts estimate HNGE EPS of $0.59 for the upcoming quarter. See Hinge Health, Inc. revenue & EPS analyst forecasts for the next four quarters with Quarter Chart Premium.

Hinge Health, Inc. (HNGE) — frequently asked questions

When does Hinge Health, Inc. (HNGE) report earnings next?

Hinge Health, Inc. is expected to report earnings on August 4, 2026 after market close. Analysts estimate EPS of $0.59.

What was HNGE's revenue last quarter?

Hinge Health, Inc. reported revenue of $182.31M in Q1 2026, up 47.2% from the same quarter a year earlier.

What was HNGE's EPS last quarter?

Hinge Health, Inc. reported diluted EPS of $0.41 in Q1 2026.

Is Hinge Health, Inc. profitable?

Hinge Health, Inc. is currently not profitable, with $-614.45M in net income over the last four reported quarters.

Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)